FindTrial
Sign In

A comparison of dosage of norepinephrine drug and phenylephrine drug in the treatment of low blood pressure during spinal anaesthesia for caesarean section

A comparison of bolus doses of norepinephrine and phenylephrine in the treatment of hypotension during spinal anaesthesia for caesarean section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039587
Enrollment
52
Registered
2022-01-20
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O746- Other complications of spinal andepidural anesthesia during labor and delivery Health Condition 2: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium

Interventions

Intervention1: Intravenous bolus doses of phenylephrine: Intravenous bolus doses of phenylephrine 50mcg is given when blood pressure falls below 20% from baseline Control Intervention1: Intravenous bo

Sponsors

DR RESHMA BALAKRISHNAN
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.age 20-40 years 2.singleton pregnanccy 3.ASA-2

Exclusion criteria

Exclusion criteria: 1.patients who refuses to give informed consent. 2.allergic to study medication. 3.maternal height less than 145cm and more than 170cm. 4.pregnancy induced hypertension, cardiovascular or cerebrovascular diseases. 5.preterm gestation or multiple gestation. 6.any contraindication to spinal anaesthesia. 7.level of subarachnoid block >T4.

Design outcomes

Primary

MeasureTime frame
MATERNAL-number of boluses of vassopressors, HR, SBP,DBP and MAP Timepoint: 20% below baseline—

Secondary

MeasureTime frame
Neonatal acid base status and APGAR scoreTimepoint: Apgar score at 1 and 5min , acid base status within 5min of cord clamping—

Countries

India

Contacts

Public ContactGifty Alexander

Pushpagiri institute of medical sciences and research centre,thiruvalla

Shailender2002@gmail.com08129832329

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026